2CP-27048-49445
4 vaccinations
7 coded responses
12 check-ins
7 free-text entries
5 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 303 / GA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
-
2020-12-28
Survey response — days 1–6 daily, dose 1MedDRA: Chills, Myalgia, Pain, Pyrexia — Feeling: Good · Site: Pain · Be unable to do your normal daily activitiesFree text: I had severe body aches, muscle aches fever and chills on the day after the vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-28
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-29
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-03-23
Survey response — 3 months, dose 1MedDRA: Dyspnoea, Pulmonary pain — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Lung pain , some increased shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Report sent to call center — 3 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-25
-
2021-06-22
Survey response — 6 months, dose 1MedDRA: Chest discomfort, Chest pain, Dyspnoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Increased shortness of breath and chest pain and chest pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-22
Report sent to call center — 6 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-28
-
2021-10-10
Dose 3 — Pfizer-BioNTech
- 2021-12-22
-
2022-01-09
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: I contracted Covid again last week, usual symptoms, for Covid and long haul symptoms flared upMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-11
- 2022-01-14
-
2022-04-12
Survey response — 6 months, dose 3MedDRA: COVID-19, Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: I had contracted Covid a second time, January 1st Exacerbated my long Covid symptoms and developed new onesMedDRA releases: 2024-11 · check-in free text available
-
2022-05-05
Dose 4 — Pfizer-BioNTech
-
2022-06-04
Survey response — day 28, dose 4MedDRA: Malaise — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Long Covid symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-06-16
Survey response — day 42, dose 4MedDRA: COVID-19, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fluctuating post Covid symptoms that worsened after getting Covid again in JanuaryMedDRA releases: 2024-11 · check-in free text available
-
2022-06-16
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-17
- 2022-06-17
- 2022-06-17
- 2022-06-17
- 2022-08-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | No |
| 3 | 2021-10-10 | Pfizer-BioNTech | No |
| 4 | 2022-05-05 | Pfizer-BioNTech | No |
Call center
5 call center cases
4 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): I had severe body aches, muscle aches fever and chills on the day after the vaccination
Release 6 — 3 months, dose 1
Symptoms: Lung pain , some increased shortness of breath
Release 9 — 6 months, dose 1
Symptoms: Increased shortness of breath and chest pain and chest pressure
Release 10 — 3 months, dose 3
Symptoms: I contracted Covid again last week, usual symptoms, for Covid and long haul symptoms flared up
Release 11 — 6 months, dose 3
Symptoms: I had contracted Covid a second time, January 1st Exacerbated my long Covid symptoms and developed new ones
Release 11 — day 28, dose 4
Symptoms: Long Covid symptoms
Release 12 — day 42, dose 4
Symptoms: Fluctuating post Covid symptoms that worsened after getting Covid again in January
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest discomfort | ✓ | ✓ | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pulmonary pain | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release